Delivery of sTRAIL variants by MSCs in combination with cytotoxic drug treatment leads to p53-independent enhanced antitumor effects
| Image |  |
|---|---|
| Description | scientific article published on 21 February 2013 |
| Author/s |
author: Ralf Michael Zwacka Andrea Mohr |
| Publication date | February 21, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |